1. Home
  2. MRNA vs MAS Comparison

MRNA vs MAS Comparison

Compare MRNA & MAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • MAS
  • Stock Information
  • Founded
  • MRNA 2010
  • MAS 1929
  • Country
  • MRNA United States
  • MAS United States
  • Employees
  • MRNA N/A
  • MAS N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • MAS Industrial Specialties
  • Sector
  • MRNA Health Care
  • MAS Industrials
  • Exchange
  • MRNA Nasdaq
  • MAS Nasdaq
  • Market Cap
  • MRNA 10.6B
  • MAS 16.7B
  • IPO Year
  • MRNA 2018
  • MAS N/A
  • Fundamental
  • Price
  • MRNA $24.66
  • MAS $62.23
  • Analyst Decision
  • MRNA Hold
  • MAS Buy
  • Analyst Count
  • MRNA 20
  • MAS 13
  • Target Price
  • MRNA $51.94
  • MAS $72.04
  • AVG Volume (30 Days)
  • MRNA 8.6M
  • MAS 2.7M
  • Earning Date
  • MRNA 05-01-2025
  • MAS 04-23-2025
  • Dividend Yield
  • MRNA N/A
  • MAS 2.01%
  • EPS Growth
  • MRNA N/A
  • MAS N/A
  • EPS
  • MRNA N/A
  • MAS 3.66
  • Revenue
  • MRNA $3,177,000,000.00
  • MAS $7,703,000,000.00
  • Revenue This Year
  • MRNA N/A
  • MAS N/A
  • Revenue Next Year
  • MRNA $22.14
  • MAS $4.02
  • P/E Ratio
  • MRNA N/A
  • MAS $16.86
  • Revenue Growth
  • MRNA N/A
  • MAS N/A
  • 52 Week Low
  • MRNA $23.15
  • MAS $56.55
  • 52 Week High
  • MRNA $170.47
  • MAS $86.70
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 42.25
  • MAS 47.91
  • Support Level
  • MRNA $23.70
  • MAS $59.96
  • Resistance Level
  • MRNA $28.52
  • MAS $62.68
  • Average True Range (ATR)
  • MRNA 1.34
  • MAS 1.84
  • MACD
  • MRNA -0.03
  • MAS 0.54
  • Stochastic Oscillator
  • MRNA 29.80
  • MAS 63.19

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About MAS Masco Corporation

Masco manufactures a variety of home improvement and building products. The company's $5-billion plumbing segment, led by the Delta and Hansgrohe brands, sells faucets, showerheads, and other related plumbing fixtures and components. The $3-billion decorative architectural segment primarily sells paints and other coatings under the Behr and Kilz brands, but it also sells builder hardware and lighting products.

Share on Social Networks: